{"entity":{"id":"nct07581314","kind":"trial","name":"Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC)","aka":[],"tldr":"A phase 1/2 trial in triple-negative breast cancer, run by Telomir Pharmaceuticals, Inc., not yet recruiting.","summary":"Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC) is a phase 1/2, interventional study registered as NCT07581314 by Telomir Pharmaceuticals, Inc., with a registry enrolment figure of 76 participants, started 2026-10 and due to reach its primary completion in 2027-05. Interventions recorded: Zn-Telomir. Conditions listed: Triple-Negative Breast Cancer (TNBC); Advanced Triple-Negative Breast Cancer; Metastatic Triple-negative Breast Cancer. Triple-negative eligibility wording from the registry: \"Clinically defined histologically or cytologically confirmed triple-negative breast cancer (TNBC)\". No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07581314","url":"https://clinicaltrials.gov/study/NCT07581314"}],"tags":["ctgov-ingest","tnbc-deep-dive"],"related":[],"cancers":["tnbc-metastatic"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07581314","phase":"1/2","setting":"A First-in-Human (FIH), Phase I/II, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Antitumor Activity of Zn-Telomir Administered Orally as Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC)","sponsor":"Telomir Pharmaceuticals, Inc.","enrolled":76,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07581314/","neighbours":{"cancer":[{"id":"tnbc-metastatic","kind":"cancer","name":"Metastatic triple-negative breast cancer","route":"/cancers/tnbc-metastatic/"}],"term":[{"id":"tnbc-trials-open-today","kind":"term","name":"Triple-negative breast cancer trials open today (registry snapshot and UK sites)","route":"/terms/tnbc-trials-open-today/"}]}}